Mycosis fungoides after treatment with tumor necrosis factor-alpha inhibitors for psoriasis: progression or onset?

Int J Dermatol. 2019 May;58(5):e103-e105. doi: 10.1111/ijd.14367. Epub 2019 Jan 3.

Authors

Felipe Partarrieu-Mejías¹, Tania Díaz-Corpas², Amparo Pérez-Ferriols³, Victor Alegre-de Miquel³

Affiliations

¹ Dermatology Resident, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
² Department of Dermatology, Hospital de Requena, Valencia, Spain.
³ Department of Dermatology, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.

PMID: 30604561
DOI: 10.1111/ijd.14367

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Biopsy
Disease Progression
Etanercept / adverse effects
Female
Humans
Immunosuppressive Agents / adverse effects*
Male
Middle Aged
Mycosis Fungoides / complications
Mycosis Fungoides / diagnosis*
Mycosis Fungoides / pathology
Psoriasis / complications
Psoriasis / drug therapy*
Psoriasis / pathology
Skin / drug effects
Skin / pathology
Skin Neoplasms / complications
Skin Neoplasms / diagnosis*
Skin Neoplasms / pathology
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Immunosuppressive Agents
TNF protein, human
Tumor Necrosis Factor-alpha
Etanercept